Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene

Clinical and Experimental Immunology

Volumn 130, Issue 2, 2002, Pages 212-223

  De Kozak, Y ^a   Thillaye Goldenberg, B ^a   Naud, M C ^a   Viana Da Costa, A ^b   Auriault, C ^b   Verwaerde, C ^b  

^a INSERM   (France)

^b INSTITUT DE BIOLOGIE DE LILLE   (France)

Author keywords

Adenovirus; Autoimmunity; Cytokines; Gene therapy; Inflammation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 2; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; MONOCLONAL ANTIBODY; RETINA S ANTIGEN; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CONJUNCTIVA; CONTROLLED STUDY; EYE; EYE DISEASE; FEMALE; GENE TRANSFER; IMMUNE RESPONSE; IMMUNIZATION; INJECTION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA; SERUM; SINUS VENOSUS; SPLEEN CELL; SUPERNATANT; UVEORETINITIS; VIRUS GENE;

ADENOVIRIDAE; ANIMALS; AUTOIMMUNE DISEASES; BETA-GALACTOSIDASE; CELLS, CULTURED; CONJUNCTIVA; EYE; EYE PROTEINS; FEMALE; GENE THERAPY; GENES, VIRAL; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; IMMUNOGLOBULIN G; INJECTIONS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-10; LUMINESCENT PROTEINS; MALE; MICE; RATS; RATS, INBRED LEW; RETINITIS; RETINOL-BINDING PROTEINS; TH1 CELLS; UVEITIS;

EID: 0036406868     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01969.x     Document Type: Article

References (60)

1. Faure JP. Autoimmune disease of the retina. In: Bona CA, Siminovitch KA, Zanetti M, Theofilopoulos AN, eds. The Molecular Pathology of Autoimmune Diseases. Langhorne, PA: Harwood Academic Publications, 1993:651-72.
2. Nussenblatt RB, Gery I. Experimental autoimmune uveitis and its relationship to clinical ocular inflammatory diseases. J Autoimmunity 1996;9:575-85.
3. Caspi RR, Roberge FG, Chan CC et al. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol 1988;140:1490-5.
4. de Kozak Y, Mirshahi M, Boucheix C, Faure JP. Inhibition of experimental autoimmune uveoretinitis in rats by S-antigen specific antibodies. Eur J Immunol 1985; 15:1107-11.
5. Caspi RR, Roberge FG, McAllister CC et al. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in rat. J Immunol 1986; 136:928-33.
6. Caspi RR, Silver PB, Chan CC et al. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. J Immunol 1996; 157:2668-75.
7. Rizzo LV, Xu H, Chan CC, Wiggert B, Caspi RR. IL-10 has a protective role in experimental autoimmune uveoretinitis. Int Immunol 1998; 10:807-14.
8. Saoudi A, Hurez V, de Kozak Y et al. Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis. Int Immunol 1993; 5:1559-67.
9. Rizzo LV, Morawetz RA, Miller-Rivero NE et al. IL-4 and IL-10 are both required for the induction of oral tolerance. J Immunol 1999; 162:2613-22.
10. Laliotou B, Duncan L, Dick AD. Intranasal administration of retinal antigens induces transient T cell activation within drainage lymph nodes but not spleen. J Autoimmunity 1999; 12:145-55.
11. Hara Y, Caspi RR, Wiggert B, Chan CC, Wilbanks GA, Streilein JW. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein. J Immunol 1992; 15:1685-92.
12. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas Ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270:1189-92.
13. Ferguson TA. The molecular basis of anterior associated immune deviation (ACAID). Ocul Immunol Inflamm 1997; 5:213-5.
14. Fiorentino DF, Bond MW, Mossman TM. Two types of mouse helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170:2081-95.
15. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science 1990; 248:1230-4.
16. O'Garra A, Stapleton G, Dhar V et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 1990; 2:821-32.
17. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes. An autoregulatory role of IL-10 produced by monocytes. J Exp Med, 1991; 174 (5):120-9.
18. Vieira P, de Waal-malefyt R, Dang MN et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRF1. Proc Natl Acad Sci USA 1991; 88:1172-6.
19. Go NF, Castle BE, Barrett R et al. Interleukin-10, a novel B cell stimulatory factor, unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med 1990; 172:1625-31.
20. Chen WF, Zlotnik A. IL-10: A novel cytotoxic T cell differentiation factor. J Immunol 1991; 14:528-34.
21. Hsu DH, de Waal Malefyt R, Fiorentino DF et al. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 1990; 250:830-2.
22. Thompson-Snipes L, Dhar V, Bond MW, Mossman TR, Moore KW, Rennick DM. Interleukin 10: A novel stimulatory factor for mast cells and their progenitors. J Exp Med 1991; 173:507-10.
23. + T lymphocyte migration. J Immunol 1993; 151:4545-51.
24. MacNeil IA, Suda T, Moore KW, Mossman TR, Zlotnik A. IL-10, a novel growth cofactor for mature and immature T cells. J Immunol 1990; 145:4167-73.
25. Hayashi S, Guez-Crosier Y, Delavaux T, Velu T, Roberge FR. Interleukin 10 inhibits inflammatory cells infiltration in endotoxin-induced uveitis. Graefe's Arch Clin Exp Ophthalmol 1996; 234:633-6.
26. Rosenbaum JT, Angell E. Paradoxical effects of IL-10 in endotoxin-induced uveitis. J Immunol 1995; 155:4090-4.
27. Qin L, Chavin KD, Ding Y et al. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograph survival. J Immunol 1996; 156:2316-23.
28. David A, Chetritt J, Guillot C et al. Interleukin-10 produced by recombinant adenovirus prolongs survival of cardiac allografts in rats. Gene Ther 2000; 7:505-10.
29. Mathisen P, Yu M, Johnson J, Drazba J, Tuohy V. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J Exp Med 1997; 186:159-64.
30. Apparailly F, Verwaerde C, Jacquet C, Auriault C, Sany J, Jorgensen C. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol 1998; 160:5213-20.
31. Ma Y, Thornton S, Duwel L et al. Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer. J Immunol 1998; 161:1516-24.
32. Pennline KJ, Roque-Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 1994; 71:169-75.
33. Lechman E, Jaffurs D, Ghivizzani S et al. Direct adenoviral gene transfer of viral IL-10 to rabbit knee with experimental arthritis ameliorates disease in both injected and controlateral knees. J Immunol 1999; 163:2202-8.
34. Whalen JD, Lechman EL, Carlos CA et al. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol 1999; 162:3625-32.
35. Quattrocchi E, Dallman MJ, Dhillon AP, Quaglia A, Bagnato G, Feldmann M. Murine IL-10 gene transfer inhibits established collagen-induced arthritis and reduces adenovirus-mediated inflammatory responses in mouse liver. J Immunol 2001; 166:5970-8.
36. Mashhour B, Couton D, Perricaudet M, Briand P. In vivo adenovirus-mediated gene transfer into ocular tissues. Gene Ther 1994; 1:122-6.
37. Hoffman LM, Maguire AM, Bennett J. Cell-mediated immune response and stability of intraocular transgene expression after adenovirus-mediated delivery. Invest Ophthalmol Vis Sci 1997; 38:2224-33.
38. Di Polo A, Aigner LJ, Dunn RJ, Bray GM, Aguayo AJ. Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Muller cells temporarily rescues injured retinal ganglion cells. Proc Natl Acad Sci U S A 1998; 95:3978-83.
39. Akimoto M, Miyatake S, Kogishi J et al. Adenovirally expressed basic fibroblast growth factor rescues photoreceptor cells in RCS rats. Invest Ophthalmol Vis Sci 1999; 40:273-9.
40. Weise J, Isenmann S, Klocker N et al. Adenovirus-mediated expression of ciliary neurotrophic factor (CNTF) rescues axotomized rat retinal ganglion cells but does not support axonal regenerationin vivo. Neurobiol Dis 2000; 7:212-23.
41. Pepperberg D, Okajima T, Ripps H, Chader GJ, Wiggert B. Functional properties ofinterphotoreceptor retinoid-binding protein. Photochem Photobiol 1991; 54:1057-60.
42. Thillaye-Goldenberg B, Goureau O, Naud MC, de Kozak Y. Delayed onset and decreased severity of experimental autoimmune uveoretinitis in mice lacking nitric oxide synthase 2. J Neuroimmunol 2000; 110:31-44.
43. Verwaerde C, Thiam K, Delanoye A, Fernandez-Gomez R, D'Halluin JC, Auriault C. Systemic delivery of an adenovirus expressing EBV-derived IL-10 in mice infected with Schistosoma mansoni or Leishmania amazonensis: Controversial effects on the development of pathological parameters. Eur Cytokine Netw 1999; 10:161-6.
44. Graham FL, Prevec L. Adenovirus-based expression vectors and recombinant vaccines. Biotechnology 1992; 20:363-90 Review.
45. Rolling F, Shen WY, Tabarias H, Constable I, Kanagasingam C, Rakoczy PE. Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography. Human Gene Ther 1999; 10:641-8.
46. Pouvreau I, Zech JC, Thillaye-Goldenberg B, Naud MC, Van Rooijen N, de Kozak Y. Effect of macrophage depletion by liposomes containing dichloromethylene diphosphonate on endotoxin-induced uveitis. J Neuroimm 1998; 86:171-81.
47. Caspi RR, Chan CC, Leake W, Higushi M, Wiggert B, Chader GJ. Experimental autoimmune uveoretinitis in mice. Induction by simple elicitating event and dependence on quantitative parameters of immunization. J Autoimm 1990; 3:237-46.
48. Ramanathan S, de Kozak Y, Saoudi A et al. Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats. J Immunol 1996; 157:2209-15.
49. Okada A, Sakai J, Usui M, Mizukichi J. Intraocular cytokine quantification of experimental autoimmune uveoretinitis in rats. Ocul Immunol Inflamm 1998; 6:111-20.
50. + expression and decreased IL-10 in the anterior chamber in idiopathic uveitis. Invest Ophthalmol Vis Sci 1999; 40:2019-24.
51. Lincoff H, Stanga P, Movshovich A et al. Choroidal concentration of interferon after retrobulbar injection. Invest Ophthalmol Vis Sci 1996; 37:2768-71.
52. Rabiah PK, Fiscella RG, Tessler HH. Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis. Invest Ophthalmol Vis Sci 1996; 37:613-8.
53. Rootman J, Bussanich N, Gudauskas G, Kumi C. Effects of subconjunctivally injected antineoplastic agents on three models of corneal inflammation. Can J Ophthalmol 1985; 20:142-6.
54. de Kozak Y, Verwaerde C. Cytokines in immunotherapy of experimental uveitis. Intern Rev Immunol 2002; 21:1-23.
55. Tu EY, Culbertson WW, Pflugfelder SC, Huang A, Chodosh JC. Therapy of non-necrotizing anterior scleritis with subconjunctival corticosteroid injection. Ophthalmology 1995; 102:718-24.
56. Souli M, Kopsinis G, Kavouklis E, Gabriel L, Giamarellou H. Vancomycin levels in human aqueous humour after intravenous and subconjunctival administration. Int J Antimicrob Agents 2001; 18:239-43.
57. Sun B, Sun SH, Chan CC, Caspi RR. Evaluation of in vivo cytokine expression in EAU-susceptible and resistant rats: A role for IL-10 in resistance. Exp Eye Res 2000; 70:493-502.
58. de Kozak Y, Thillaye-Goldenberg B, Naud MC, Auriault C, Verwaerde C.In vivo transfer of vIL-10 by injection into rat vitreous of rat retinal Müller glial cells infected with recombinant adenovirus. Invest Ophthalmol Vis Sci 2001; 42:S914.
59. Nussenblatt RB, Palestine AG. Uveitis: Fundamentals and Clinical Practice. Chicago: Yearbook Medical Publishers, 1989.
60. Dick AD. Immune mechanisms of uveitis: Insights into disease pathogenesis and. Treatment Int Ophthalmol Clin 2000; 40:1-18.